Scholarlink

<p>Adrenomyeloneuropathy (AMN) is a form of the X-linked adrenoleukodystrophy (ALD), a rare peroxisomal beta-oxidation disorder causing the accumulation of very long-chain fatty acids (VLCFAs) in adrenal cortex and central and peripheral nervous system. We present the case of a 48-year-old man with genetically confirmed AMN, who presented to the Emergency Department with convulsive status epilepticus. The brain MRI showed extensive leukoencephalopathy and demyelination involving bilateral subcortical and deep white matter, corticospinal tracts, corpus callosum and the pons. Correction of laboratory abnormalities and therapy with intravenous levetiracetam, oral phenytoin and perampanel led to significant clinical improvement and resolution of the seizures. Convulsive status epilepticus may be a clinical manifestation of X-linked AMN.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Status epilepticus as clinical manifestation of adrenomyeloneuropathy: a rare association

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月22日

查看全文
  • Sandra Perillo,
  • Roberto Allocca,
  • Francesco Barbato,
  • Teresa Perillo,
  • Giorgio Bosso,
  • Antonio Pinto,
  • Fabio Giuliano Numis

摘要

Adrenomyeloneuropathy (AMN) is a form of the X-linked adrenoleukodystrophy (ALD), a rare peroxisomal beta-oxidation disorder causing the accumulation of very long-chain fatty acids (VLCFAs) in adrenal cortex and central and peripheral nervous system. We present the case of a 48-year-old man with genetically confirmed AMN, who presented to the Emergency Department with convulsive status epilepticus. The brain MRI showed extensive leukoencephalopathy and demyelination involving bilateral subcortical and deep white matter, corticospinal tracts, corpus callosum and the pons. Correction of laboratory abnormalities and therapy with intravenous levetiracetam, oral phenytoin and perampanel led to significant clinical improvement and resolution of the seizures. Convulsive status epilepticus may be a clinical manifestation of X-linked AMN.